{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:48:04Z","timestamp":1770817684328,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,12,28]],"date-time":"2011-12-28T00:00:00Z","timestamp":1325030400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s00432-011-1130-x","type":"journal-article","created":{"date-parts":[[2011,12,27]],"date-time":"2011-12-27T05:59:18Z","timestamp":1324965558000},"page":"359-361","source":"Crossref","is-referenced-by-count":7,"title":["Mutational activation of FGFR3: no involvement in the development of renal cell carcinoma"],"prefix":"10.1007","volume":"138","author":[{"given":"C. G.","family":"Stoehr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Stoehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Hofstaedter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Junker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Blaszyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. F.","family":"Wieland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Otto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Denzinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,28]]},"reference":[{"issue":"3","key":"1130_CR1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00467-006-0239-7","volume":"22","author":"M Bates","year":"2007","unstructured":"Bates M (2007) Role of fibroblast growth factor receptor signaling in kidney development. Pediatr Nephrol 22(3):343\u2013349","journal-title":"Pediatr Nephrol"},{"key":"1130_CR2","first-page":"315","volume":"27","author":"E Cenni","year":"2007","unstructured":"Cenni E, Perut F, Granchi D, Avnet S, Amato I, Brandi ML, Giunti A et al (2007) Inhibition of angiogenesis via FGF-2 blockage in primitive and bone metastatic renal cell carcinoma. Anticancer Res 27:315\u2013320","journal-title":"Anticancer Res"},{"issue":"9","key":"1130_CR3","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1432-0436.2007.00210.x","volume":"75","author":"CL Chaffer","year":"2007","unstructured":"Chaffer CL, Dopheide B, Savagner P, Thompson EW, Williams ED (2007) Aberrant fibroblast growth factor receptor signaling in bladder and other cancers. Differentiation 75(9):831\u2013842","journal-title":"Differentiation"},{"issue":"3","key":"1130_CR4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0302-2838(03)00005-8","volume":"43","author":"MV Cronauer","year":"2003","unstructured":"Cronauer MV, Schulz WA, Seifert HH, Ackermann R, Burchardt M (2003) Fibroblast growth factors and their receptors in urological cancers: basic research and clinical implications. Eur Urol 43(3):309\u2013319","journal-title":"Eur Urol"},{"key":"1130_CR5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1349-7006.1995.tb03037.x","volume":"86","author":"K Fujimoto","year":"1995","unstructured":"Fujimoto K, Ichimori Y, Yamaguchi H et al (1995) Basic fibroblast growth factor as a candidate tumor marker for renal cell carcinoma. Jpn J Cancer Res 86:182\u2013186","journal-title":"Jpn J Cancer Res"},{"key":"1130_CR9","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3656-4","volume-title":"American Joint Committee on Cancer (AJCC) Cancer staging manual","author":"FL Greene","year":"2002","unstructured":"Greene FL, Page DL, Fleming ID, Fritz AG, Batch CM, Haller DG, Morrow M (2002) American Joint Committee on Cancer (AJCC) Cancer staging manual. Springer, New York"},{"key":"1130_CR6","unstructured":"Grignon DJ, Eble JN, Bonsib SM, Moch H, Delahunt B, St\u00f6rkel S, Pavlovich CP et al (2004) Tumours of the kidney. In: Pathology and genetics of tumours of the urinary system and male genital organs. IARC Press, Lyon, pp 10\u201334"},{"key":"1130_CR7","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1172\/JCI28163","volume":"116","author":"C Hafner","year":"2006","unstructured":"Hafner C, van Oers JM, Vogt T, Landthaler M, Stoehr R, Blaszyk H, Hofstaedter F, Zwarthoff EC, Hartmann A (2006) Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi. J Clin Invest 116:2201\u20132207","journal-title":"J Clin Invest"},{"key":"1130_CR8","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.urology.2009.02.078","volume":"74","author":"P Hajj","year":"2009","unstructured":"Hajj P, Ferlicot S, Massoud W, Awad A, Hammoudi Y, Charpentier B, Durrbach A, Droupy S, Beno\u00eet G (2009) Prevalence of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease and chronic renal failure. Urology 74:631\u2013634","journal-title":"Urology"},{"key":"1130_CR10","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/(SICI)1097-0215(19960301)65:5<650::AID-IJC15>3.0.CO;2-B","volume":"65","author":"Y Myoken","year":"1996","unstructured":"Myoken Y, Myoken Y, Okamoto T, Kan M, McKeehan WL, Sato JD, Takada K (1996) Expression of fibroblast growth factor-1 (FGF-1), FGF-2 and FGF receptor-1 in a human salivary-gland adenocarcinoma cell line: evidence of autocrine growth. Int J Cancer 65:650\u2013657","journal-title":"Int J Cancer"},{"issue":"4","key":"1130_CR11","first-page":"407","volume":"17","author":"P Prontera","year":"2006","unstructured":"Prontera P, Sensi A, Pilu G, Baldi M, Baffico M, Bonasoni R, Calzolari E (2006) FGFR3 mutation in thanatophoric dysplasia type 1 with bilateral cystic renal dysplasia: coincidence or a new association? Genet Couns 17(4):407\u2013412","journal-title":"Genet Couns"},{"issue":"2","key":"1130_CR12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0925-4773(01)00592-5","volume":"109","author":"J Qiao","year":"2001","unstructured":"Qiao J, Bush KT, Steer DL, Stuart RO, Sakurai H, Wachsman W, Nigam SK (2001) Multiple fibroblast growth factors support growth of the ureteric bud but have different effects on branching morphogenesis. Mech Dev 109(2):123\u2013135","journal-title":"Mech Dev"},{"key":"1130_CR13","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1111\/j.1523-1755.2005.00734.x","volume":"68","author":"M Rossini","year":"2005","unstructured":"Rossini M, Cheunsuchon B, Donnert E, Ma LJ, Thomas JW, Neilson EG, Fogo AB (2005) Immunolocalization of fibroblast growth factor-1 (FGF-1), its receptor (FGFR-1), and fibroblast-specific-protein-1 (FSP-1) in inflammatory renal disease. Kidney Int 68:2621\u20132628","journal-title":"Kidney Int"},{"issue":"32","key":"1130_CR14","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1038\/sj.onc.1204543","volume":"20","author":"K Sibley","year":"2001","unstructured":"Sibley K, Stern P, Knowles MA (2001) Frequency of fibroblast growth factor receptor 3 mutations in sporadic tumours. Oncogene 20(32):4416\u20134418","journal-title":"Oncogene"},{"key":"1130_CR18","volume-title":"TNM Classification of Malignant Tumors","author":"LH Sobin","year":"2002","unstructured":"Sobin LH, Wittekind C (2002) TNM Classification of Malignant Tumors. Wiley, New York, Weinheim"},{"issue":"13","key":"1130_CR15","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1093\/hmg\/ddp165","volume":"18","author":"X Song","year":"2009","unstructured":"Song X, Di Giovanni V, He N, Wang K, Ingram A, Rosenblum ND, Pei Y (2009) Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks. Hum Mol Genet 18(13):2328\u20132343","journal-title":"Hum Mol Genet"},{"issue":"3","key":"1130_CR16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/ng1975","volume":"39","author":"RK Thomas","year":"2007","unstructured":"Thomas RK, Baker AC, Debiasi RM, Meyerson M, Garraway LA et al (2007) High-throughput oncogene mutation profiling in human cancer. Nat Genet 39(3):347\u2013351","journal-title":"Nat Genet"},{"key":"1130_CR17","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1158\/1078-0432.CCR-05-1045","volume":"11","author":"JM Oers van","year":"2005","unstructured":"van Oers JM, Lurkin I, van Exsel AJ, Nijsen Y, van Rhijn BW, van der Aa MN, Zwarthoff EC (2005) A simple and fast method for the simultaneous detection of nine fibroblast growth factor receptor 3 mutations in bladder cancer and voided urine. Clin Cancer Res 11:7743\u20137748","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-011-1130-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-011-1130-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-011-1130-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:40:05Z","timestamp":1559083205000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-011-1130-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,28]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["1130"],"URL":"https:\/\/doi.org\/10.1007\/s00432-011-1130-x","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,28]]}}}